Hubei Key Laboratory of Natural Medicinal Chemistry and Resource Evaluation, School of Pharmacy, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, People's Republic of China.
Chemistry and Biochemistry, Hawaii Pacific University, Kaneohe, Hawaii 96744, United States.
J Nat Prod. 2024 Apr 26;87(4):783-797. doi: 10.1021/acs.jnatprod.3c00942. Epub 2024 Mar 27.
Waixenicin A, a xenicane diterpene from the octocoral , is a selective, potent inhibitor of the TRPM7 ion channel. To study the structure-activity relationship (SAR) of waixenicin A, we isolated and assayed related diterpenes from . In addition to known waixenicins A () and B (), we purified six xenicane diterpenes, 7,8-epoxywaixenicins A () and B (), 12-deacetylwaixenicin A (), waixenicin E (), waixenicin F (), and 20-acetoxyxeniafaraunol B (). We elucidated the structures of - by NMR and MS analyses. Compounds , , , , and inhibited TRPM7 activity in a cell-based assay, while , , and were inactive. A preliminary SAR emerged showing that alterations to the nine-membered ring of did not reduce activity, while the 12-acetoxy group, in combination with the dihydropyran, appears to be necessary for TRPM7 inhibition. The bioactive compounds are proposed to be latent electrophiles by formation of a conjugated oxocarbenium ion intermediate. Whole-cell patch-clamp experiments demonstrated that waixenicin A inhibition is irreversible, consistent with a covalent inhibitor, and showed nanomolar potency for waixenicin B (). Conformational analysis (DFT) of , , , and revealed insights into the conformation of waixenicin A and congeners and provided information regarding the stabilization of the proposed pharmacophore.
Waixenicin A,一种来自八放珊瑚的 xenicane 二萜,是一种选择性、强效的 TRPM7 离子通道抑制剂。为了研究 waixenicin A 的结构-活性关系(SAR),我们从 中分离并测定了相关的二萜。除了已知的 waixenicins A () 和 B (), 我们还纯化了六种 xenicane 二萜,7,8-环氧 waixenicins A () 和 B (), 12-去乙酰基 waixenicin A (), waixenicin E (), waixenicin F (), 和 20-乙酰氧基 xeniafaraunol B (). 通过 NMR 和 MS 分析阐明了 - 的结构。化合物,,,, 和 在细胞测定中抑制 TRPM7 活性,而,, 和 则没有活性。初步 SAR 表明,对 的九元环的改变不会降低活性,而 12-乙酰氧基基团与二氢吡喃结合似乎是 TRPM7 抑制所必需的。生物活性化合物通过形成共轭氧碳正离子中间体被提议为潜伏的亲电试剂。全细胞膜片钳实验表明 waixenicin A 的抑制是不可逆的,与共价抑制剂一致,并且对 waixenicin B 的抑制具有纳摩尔效力()。对,,, 和 的构象分析(DFT)揭示了对 waixenicin A 和同系物构象的深入了解,并提供了关于稳定所提议的药效团的信息。